These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 15754421)
21. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes. Chézalviel-Guilbert F; Davy JM; Poirier JM; Weissenburger J J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874 [TBL] [Abstract][Full Text] [Related]
22. Investigating the effect of sotalol on the repolarization intervals in healthy young individuals. Couderc JP; Zhou M; Sarapa N; Zareba W J Electrocardiol; 2008; 41(6):595-602. PubMed ID: 18801493 [TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of corrected QT and corrected JT interval for incident coronary heart disease in a general population sample stratified by presence or absence of wide QRS complex: the ARIC Study with 13 years of follow-up. Crow RS; Hannan PJ; Folsom AR Circulation; 2003 Oct; 108(16):1985-9. PubMed ID: 14517173 [TBL] [Abstract][Full Text] [Related]
24. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study. Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956 [TBL] [Abstract][Full Text] [Related]
25. Ventricular repolarization in overweight and normal weight healthy young men. Vardar SA; Oztürk L; Altun A; Turan N Anadolu Kardiyol Derg; 2008 Feb; 8(1):27-31. PubMed ID: 18258530 [TBL] [Abstract][Full Text] [Related]
26. [Evaluation of antiarrhythmic efficacy of sotalol in various doses in patients with ventricular tachyarrhythmias]. Luczak D; Dabrowski R; Szwed H; Gasior Z; Stanke A; Jasek S; Skrabucha B; Matar A; Kowalik I Pol Merkur Lekarski; 1997 Feb; 2(8):122-5. PubMed ID: 9538657 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of oral sotalol in suppression of premature ventricular complexes and analysis of its beta-adrenergic blocking activity. Giorgi C; Nadeau R; Agha A; Primeau R; de Champlain J Can J Cardiol; 1990 Jun; 6(5):191-7. PubMed ID: 1696514 [TBL] [Abstract][Full Text] [Related]
28. Investigation of the effects of physiological and vasodilation-induced autonomic activation on the QTc Interval in healthy male subjects. Berger E; Patel K; Anwar S; Davies W; Sheridan DJ Br J Clin Pharmacol; 2005 Jul; 60(1):17-23. PubMed ID: 15963089 [TBL] [Abstract][Full Text] [Related]
29. Effect of hyperventilation on rate corrected QT interval of children. Kannivelu A; Kudumula V; Bhole V Arch Dis Child; 2013 Feb; 98(2):103-6. PubMed ID: 23241195 [TBL] [Abstract][Full Text] [Related]
30. Electrocardiographic changes after long-term treatment with sotalol in hypertensive patients. Castro M; Descamps R; Thomis JA Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):88-91. PubMed ID: 7061183 [TBL] [Abstract][Full Text] [Related]
31. Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia. Fabritz L; Kirchhof P; Franz MR; Eckardt L; Mönnig G; Milberg P; Breithardt G; Haverkamp W Basic Res Cardiol; 2003 Feb; 98(1):25-32. PubMed ID: 12494266 [TBL] [Abstract][Full Text] [Related]
32. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol. Fiset C; Drolet B; Hamelin BA; Turgeon J J Pharmacol Exp Ther; 1997 Oct; 283(1):148-56. PubMed ID: 9336319 [TBL] [Abstract][Full Text] [Related]
33. Optimisation of atrioventricular delay during exercise improves cardiac output in patients stabilised with cardiac resynchronisation therapy. Sun JP; Lee AP; Grimm RA; Hung MJ; Yang XS; Delurgio D; Leon AR; Merlino JD; Yu CM Heart; 2012 Jan; 98(1):54-9. PubMed ID: 21880650 [TBL] [Abstract][Full Text] [Related]
34. Randomized double blind trial comparing sotalol and propranolol in chronic ventricular arrhythmia. Kubac G; Klinke WP; Grace M Can J Cardiol; 1988 Oct; 4(7):355-9. PubMed ID: 3067834 [TBL] [Abstract][Full Text] [Related]
35. A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism. Funck-Brentano C; Silberstein DJ; Roden DM; Wood AJ; Woosley RL Br J Clin Pharmacol; 1990 Aug; 30(2):195-202. PubMed ID: 2169833 [TBL] [Abstract][Full Text] [Related]
36. Assessment of QT and JT Intervals in Patients With Left Bundle Branch Block. Tabatabaei P; Keikhavani A; Haghjoo M; Fazelifar A; Emkanjoo Z; Zeighami M; Bakhshandeh H; Ghadrdoost B; Alizadeh A Res Cardiovasc Med; 2016 May; 5(2):e31528. PubMed ID: 26949694 [TBL] [Abstract][Full Text] [Related]
37. Examination of New Electrocardiographic Repolarization Markers in Diabetic Patients with Noncritical Coronary Artery Disease. Gürler M; İnanır M Int J Clin Pract; 2022; 2022():5766494. PubMed ID: 35685512 [TBL] [Abstract][Full Text] [Related]
38. A comparison of the cardiovascular effects of (+)-sotalol and (+/-)-sotalol following intravenous administration in normal volunteers. Johnston GD; Finch MB; McNeill JA; Shanks RG Br J Clin Pharmacol; 1985 Nov; 20(5):507-10. PubMed ID: 4074623 [TBL] [Abstract][Full Text] [Related]